Apple Tree Partners. a pioneer in life sciences venture capital, is developing the next generation of transformative biotechnology companies.
We create science-based companies starting with assets at various stages: from working with scientists on pre-IP ideas, to spinouts from existing company pipelines.
We provide flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises.
We invest in our companies from seed stage through IPO and beyond, and we support our management teams in strategic transactions and synergistic business combinations.
Akero Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for Efruxifermin (EFX) in NASH
First Patients Treated with Galaxy Medical’s Centauri™ Pulsed Electric Field Cardiac Ablation System
Stoke Therapeutics Announces Plans to Move Forward With Dosing of STK-001 in Children and Adolescents in Ongoing Phase 1/2a MONARCH Study for Dravet Syndrome
Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement Financing
Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics
Akero Therapeutics Completes Enrollment of Cohort of Cirrhotic (F4) Patients In Ongoing Balanced Study